Outstanding Clinical Outcomes
Platinum Chromium Everolimus-Eluting Clinical Experience
Excellent Safety and Performance with Promus PtCr EES1
- Over 10,000 Patients Studied
- Over 1 Million Implants
The Promus PREMIERTM Stent is the newest member of the PROMUSTM family, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.